Article thumbnail

Efficacy of 5mer4 in combination with HBsAg.

By Ami Patel (139999), Jessica C. Dong (140003), Brett Trost (140006), Jason S. Richardson (140010), Sarah Tohme (140013), Shawn Babiuk (140018), Anthony Kusalik (140024), Sam K. P. Kung (138502) and Gary P. Kobinger (49841)

Abstract

<p>Exogenous 5mer4 (50 µg) was combined with a commercial Hepatitis B vaccine (Engerix-B, 1 µg). Control mice received the commercial vaccines without 5mer4. Serum was collected from vaccinated animals at 2 •, 4 ▪, 6 ▴, and 8 ▾ weeks post-immunization and evaluated in two-fold dilutions for detection by ELISA. Antibody levels were detected at OD450 nm. (a) Anti-HBsAg antibodies following vaccination with Engerix-B + 5mer4. (b) Anti-HBsAg antibodies following vaccination with Engerix-B alone. Inset displays the data within a more narrow y-axis range. The data represents the arithmetic mean titre ± SEM.</p

Topics: Biochemistry, Microbiology, Immunology, 5mer4
Year: 2012
DOI identifier: 10.1371/journal.pone.0043802.g004
OAI identifier: oai:figshare.com:article/257945
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://figshare.com/articles/... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.